Role of HIV-1 Vpr in AIDS pathogenesis: Relevance and implications of intravirion, intracellular and free Vpr

Biomedicine and Pharmacotherapy

Volumn 57, Issue 1, 2003, Pages 20-24

  Tungaturthi, Parithosh K ^a   Sawaya, Bassel E ^b   Singh, Satya P ^a   Tomkowicz, Brian ^a   Ayyavoo, Velpandi ^c   Khalili, Kamel ^b   Collman, Ronald G ^d   Amini, Shohreh ^b   Srinivasan, Alagarsamy ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Temple University   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

AIDS; HIV 1; Vpr

Indexed keywords

RECOMBINANT PROTEIN; VIRUS PROTEIN; VPR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL FREE SYSTEM; CENTRAL NERVOUS SYSTEM INFECTION; CYTOPATHOGENIC EFFECT; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN FUNCTION; VIRION; VIRUS PATHOGENESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; GENE PRODUCTS, VPR; HIV INFECTIONS; HIV-1; HUMANS; MODELS, BIOLOGICAL;

EID: 0037228265     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00328-1     Document Type: Article

References (29)

1. Ayyavoo V., Mahboubi A., Mahalingham S., Ramalingam R., Kudchodkar S., Williams W.V., et al. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kB. Nature M. 3:1997;1117-1123.
2. Azad A.A. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells? Biochem Biophys Res Commun. 267:2000;677-685.
3. Balliet J.W., Kolson D.L., Eiger G., Kim F.M., McGann K.A., Srinivasan A., et al. Distinct effects in primary macrophages and lymphocytes of human immunodeficiency virus type 1 accessory genes vpr,vpuand nef: Mutational analysis of a primary HIV-1 isolate. Virology. 200:1994;623-631.
4. BouHamdan M., Kulkosky J., Duan L.X., Pomerantz R.J. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies. J Human Virol. 3:2000;6-15.
5. Bukrinsky M., Adzhubei A. Viral protein R of HIV-1. Rev Med Virol. 9:1999;39-49.
6. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus Vpr product is a virion associated regulatory protein. J Virol. 64:1990;3097-3099.
7. Cohen E.A., Terwilliger E.F., Jalinoos Y., Proulx J., Sodroski J.G., Haseltine W.A. Identification of HIV-1 vpr product and function. J Acquired Immune Deficiency Syndrome. 3:1990;11-18.
8. Emerman M., Malim M.H. HIV-1 regulatory/accessory genes: keys to unravelling viral and host cell biology. Science. 280:1998;1880-1884.
9. 2 cell cycle arrest. J Biol Chem. 275:2000;32016-32026.
10. Hrimech M., Yao X- J., Bachand F., Rougeau N., Cohen E.A. Human immunodeficiency virus type 1 Vpr functions as an immediate-early protein during HIV-1 function. J Virol. 73:1999;4101-4109.
11. Huang M.B., Weeks O., Zhao L.J., Saltarelli M., Bond V.C. Effects of extracellular human immunodeficiency virus type 1 vpr protein in primary rat cortical cell cultures. J Neurovirol. 6:2000;202-220.
12. Hughes T.A., La Boissiere S., O'Hare P. Analysis of functional domains of the host cell factor involved in VP16 complex formation. J Biol Chem. 274:1999;16437-16443.
13. Hunter E. Macromolecular interactions in the assembly of HIV and other retroviruses. Sem Virol. 5:1994;71-83.
14. Kobinger G.P., Borsetti A., Nie Z., Mercier J., Daniel N., Gottlinger H.G., et al. Virion-targeted viral inactivation of human immunodeficiency virus type 1 by using Vpr fusion proteins. J Virol. 72:1988;5441-5448.
15. Lai D., Singh S.P., Cartas M., Murali R., Kalyanaraman V.S., Srinivasan A. Extent of incorporation of HIV-1 Vpr into the virus particles is flexible and can be modulated by expression level in cells. FEBS Lett. 469:2000;191-195.
16. Levy D.N., Rafaeli Y., Weiner D.B. Extracellular vpr protein increases cellular permissiveness of human immunodeficiency virus replication and reactivates virus from latency. J Virol. 69:1995;1243-1252.
17. Levy D.N., Rafaeli Y., MacGregor R.R., Weiner D.B. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc Natl Acad Sci USA. 91:1994;10873-10877.
18. Levy J.A. "HIV and the pathogenesis of AIDS" 1998;ASM Press, Washington, D.C.
19. Mellors J.W. Closing in on human immunodeficiency virus type 1. Nature M. 2:1996;274-295.
20. Muller B., Tessmer U., Schubert U., Krausslich H.G. Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J Virol. 74:2000;9727-9731.
21. Omrani A.S., Pillay D. Multi-drug resistant HIV-1. J Infect. 41:2000;5-11.
22. Patel C.A., Mukhtar M., Pomerantz R.J. Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J Virol. 74:2000;9717-9726.
23. Piller S.C. Effect of extracellular HIV-1 Vpr protein in vitro. J Neurovirol. 7:2001;183-185.
24. Piller S.C., Jans P., Gage P.W., Jans D.A., Extracellular H.I. V-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: implications for AIDS pathology. Proc Natl Acad Sci USA. 95:1998;4595-4600.
25. Poon B., Grovit-Feerbas K., Stewart S.A., Chen I.S.Y. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science. 281:1998;266-269.
26. Singh S.P., Lai D., Cartas M., Serio D., Murali R., Kalyanaraman V.S., et al. Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: amount of vpr in relation to gag in HIV-1. Virology. 268:2000;364-371.
27. Singh S.P., Tungaturthi P., Cartas M., Tomkowicz B., Rizvi T.A., Khan S.A., et al. Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection. Virology. 283:2001;78-83.
28. Vogt V.M., Simon M.N. Mass determination of Rous sarcoma virus virions by scanning transmission electron microscopy. J Virol. 73:1999;7050-7055.
29. Wu X., Liu H., Xiao H., Kim J., Seshaiah S., Natsoulis G., et al. Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol. 69:1995;3389-3398.